Regulus Therapeutics | Gewinn Vor Steuern



Gewinn Vor Steuern Veränderung Datum
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
AstraZeneca USD 3.24B 117M 2025-09
Biogen USD 557.3M 186.7M 2025-09
Celldex Therapeutics USD -67.04M 10.44M 2025-09
Cipla INR 11.69B 6.85B 2025-12
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -6.94M 421K 2025-09
CSL USD 1.4B 1.14B 2025-06
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Grifols EUR 66.98M 19.92M 2024-06
Immunic USD -21.38M 8.2M 2024-06
Incyte USD 389.94M 92.37M 2025-12
Intrexon USD -60.48M 27.09M 2024-06
Ionis Pharmaceuticals USD -129M 253M 2025-09
Lexicon Pharmaceuticals USD -53.43M 5.03M 2024-06
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
Merck USD 6.74B 22M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR -1.16B 6.23B 2025-12
Takeda JPY 133.86B 105.69B 2025-12


Regulus Therapeutics Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.